Literature DB >> 11584052

Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.

G B Mills, R C Bast, S Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11584052     DOI： 10.1093/jnci/93.19.1437

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Early detection of ovarian cancer.

Authors:  Partha M Das; Robert C Bast
Journal:  Biomark Med       Date:  2008-06       Impact factor: 2.851

2.  Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.

Authors:  Colin G Ferguson; Cleve S Bigman; Robyn D Richardson; Laurens A van Meeteren; Wouter H Moolenaar; Glenn D Prestwich
Journal:  Org Lett       Date:  2006-05-11       Impact factor: 6.005

Review 3.  Proteomics in cancer screening and management in gynecologic cancer.

Authors:  Wei Hu; Weiguo Wu; Ryuji Kobayashi; John J Kavanagh
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 4.  Proteomic profiling in ovarian cancer.

Authors:  Geoffrey Kim; Lucas Minig; Elise C Kohn
Journal:  Int J Gynecol Cancer       Date:  2009-12       Impact factor: 3.437

5.  Nidogen-2: a new serum biomarker for ovarian cancer.

Authors:  Cynthia Kuk; C Geeth Gunawardana; Antoninus Soosaipillai; Hiroshi Kobayashi; Lin Li; Yingye Zheng; Eleftherios P Diamandis
Journal:  Clin Biochem       Date:  2009-10-31       Impact factor: 3.281

Review 6.  Early events in ovarian oncogenesis.

Authors:  Dusica Cvetkovic
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

7.  Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.

Authors:  Katherine R Kozak; Malaika W Amneus; Suzanne M Pusey; Feng Su; Mui N Luong; Sam A Luong; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

8.  Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer.

Authors:  Stephen Chee Liang Koh; Chan Yiong Huak; Delfi Lutan; Johny Marpuang; Suwiyoga Ketut; Nyoma Gede Budiana; Agustria Zainu Saleh; Mohamad Farid Aziz; Hariyono Winarto; Heru Pradjatmo; Nguyen Khac Han Hoan; Pham Viet Thanh; Mahesh Choolani
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

9.  Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

Authors:  K Oikonomopoulou; L Li; Y Zheng; I Simon; R L Wolfert; D Valik; M Nekulova; M Simickova; T Frgala; E P Diamandis
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

10.  Diagnostic value of KLK6 as an ovarian cancer biomarker: A meta-analysis.

Authors:  Fan Yang; Zhi-DE Hu; Yingjian Chen; Cheng-Jin Hu
Journal:  Biomed Rep       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.